EGFR and non-small cell lung carcinoma: This comprehensive systematic review and meta-analysis assessed the efficacy of first-line treatment with upfront brain RT plus EGFR-TKIs versus EGFR-TKIs alone in patients with EGFR-mutated NSCLC with BMs.